New cancer clinical trial: NIVOLUMAB Plus IPILIMUMAB and TEMOZOLOMIDE in Microsatellite Stable, MGMT Silenced Metastatic Colorectal Cancer

Published on: February 06, 2019 at 10:30PM

• Tweet
• Share
• Share
• Share
• Share